tiprankstipranks
Trending News
More News >
Haemonetics (HAE)
NYSE:HAE
US Market

Haemonetics (HAE) Financial Statements

Compare
431 Followers

Haemonetics Financial Overview

Haemonetics's market cap is currently $3.22B. The company's EPS TTM is $1.27; its P/E ratio is 20.08; Haemonetics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $1.25. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.36B$ 1.31B$ 1.17B$ 993.20M$ 870.46M
Gross Profit$ 778.55M$ 711.91M$ 622.87M$ 530.77M$ 428.45M
Operating Income$ 221.82M$ 164.88M$ 156.03M$ 80.75M$ 89.75M
EBITDA$ 355.99M$ 295.45M$ 252.01M$ 191.72M$ 184.38M
Net Income$ 167.68M$ 117.56M$ 115.40M$ 43.38M$ 79.47M
Balance Sheet
Cash & Short-Term Investments$ 306.76M$ 178.80M$ 284.47M$ 259.50M$ 192.31M
Total Assets$ 2.45B$ 2.20B$ 1.93B$ 1.86B$ 1.82B
Total Debt$ 1.22B$ 807.79M$ 765.89M$ 780.78M$ 778.28M
Net Debt$ 918.02M$ 628.99M$ 481.42M$ 521.29M$ 585.97M
Total Liabilities$ 1.63B$ 1.24B$ 1.12B$ 1.11B$ 1.09B
Stockholders' Equity$ 820.84M$ 959.96M$ 818.00M$ 749.42M$ 731.67M
Cash Flow
Free Cash Flow$ 142.45M$ 115.45M$ 162.87M$ 75.75M$ 71.77M
Operating Cash Flow$ 181.72M$ 181.75M$ 273.06M$ 172.26M$ 108.81M
Investing Cash Flow$ -161.90M$ -322.39M$ -143.79M$ -86.34M$ -425.44M
Financing Cash Flow$ 108.82M$ 38.16M$ -100.36M$ -15.75M$ 367.45M
Currency in USD

Haemonetics Earnings and Revenue History

Haemonetics Debt to Assets

Haemonetics Cash Flow

Haemonetics Forecast EPS vs Actual EPS